Healthcare provider profile · identity verified

Julia Randall, MD

Family Practice · WORCESTER, MA · NPI 1811209836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	342	58
Gabapentin	Gabapentin	281	42
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	218	22
Lisinopril	Lisinopril	211	49
Omeprazole	Omeprazole	203	42
Metformin Hcl	Metformin Hcl	176	37
Trulicity	Dulaglutide	160	28
Amlodipine Besylate	Amlodipine Besylate	147	35
Metoprolol Succinate	Metoprolol Succinate	146	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	130	suppressed
Losartan Potassium	Losartan Potassium	121	27
Albuterol Sulfate Hfa	Albuterol Sulfate	104	26
Famotidine	Famotidine	94	17
Hydrochlorothiazide	Hydrochlorothiazide	89	20
Jardiance	Empagliflozin	84	17
Rosuvastatin Calcium	Rosuvastatin Calcium	80	21
Metformin Hcl Er	Metformin Hcl	73	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	11
Furosemide	Furosemide	70	17
Ibuprofen	Ibuprofen	70	15
Alcohol Swabs	Alcohol Antiseptic Pads	68	16
Levothyroxine Sodium	Levothyroxine Sodium	67	14
Diclofenac Sodium	Diclofenac Sodium	61	18
Tramadol Hcl	Tramadol Hcl	56	suppressed
Mirtazapine	Mirtazapine	52	14
Simvastatin	Simvastatin	51	11
Tamsulosin Hcl	Tamsulosin Hcl	51	13
Fluticasone Propionate	Fluticasone Propionate	50	16
Chlorthalidone	Chlorthalidone	44	suppressed
Eliquis	Apixaban	40	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Sertraline Hcl	Sertraline Hcl	38	suppressed
Ammonium Lactate	Ammonium Lactate	36	suppressed
Carvedilol	Carvedilol	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Trazodone Hcl	Trazodone Hcl	33	suppressed
Meclizine Hcl	Meclizine Hcl	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	12
Betamethasone Dipropionate	Betamethasone Dipropionate	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Vivitrol	Naltrexone Microspheres	30	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Allopurinol	Allopurinol	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	11
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Glipizide	Glipizide	20	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Finasteride	Finasteride	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Prednisone	Prednisone	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Naproxen	Naproxen	15	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	13
Sublocade	Buprenorphine	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Acamprosate Calcium	Acamprosate Calcium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Jublia	Efinaconazole	11	suppressed
Lactulose	Lactulose	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error